Tekla Capital Management’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-233,612
| Closed | -$1.56M | – | 201 |
|
|
2020
Q4 | $1.56M | Hold |
233,612
| – | – | 0.05% | 166 |
|
|
2020
Q3 | $1.18M | Hold |
233,612
| – | – | 0.04% | 175 |
|
|
2020
Q2 | $1.89M | Sell |
233,612
-332,454
| -59% | -$2.69M | 0.07% | 164 |
|
|
2020
Q1 | $4.5M | Sell |
566,066
-248,522
| -31% | -$1.97M | 0.2% | 91 |
|
|
2019
Q4 | $6.15M | Hold |
814,588
| – | – | 0.23% | 90 |
|
|
2019
Q3 | $3.39M | Hold |
814,588
| – | – | 0.15% | 107 |
|
|
2019
Q2 | $2.35M | Hold |
814,588
| – | – | 0.1% | 126 |
|
|
2019
Q1 | $1.17M | Hold |
814,588
| – | – | 0.05% | 153 |
|
|
2018
Q4 | $2.1M | Hold |
814,588
| – | – | 0.09% | 126 |
|
|
2018
Q3 | $3.58M | Hold |
814,588
| – | – | 0.13% | 114 |
|
|
2018
Q2 | $4.99M | Hold |
814,588
| – | – | 0.19% | 91 |
|
|
2018
Q1 | $5.94M | Buy |
814,588
+190,300
| +30% | +$1.39M | 0.23% | 86 |
|
|
2017
Q4 | $5.12M | Hold |
624,288
| – | – | 0.2% | 90 |
|
|
2017
Q3 | $6.56M | Hold |
624,288
| – | – | 0.23% | 74 |
|
|
2017
Q2 | $6.89M | Hold |
624,288
| – | – | 0.26% | 74 |
|
|
2017
Q1 | $6.04M | Hold |
624,288
| – | – | 0.23% | 77 |
|
|
2016
Q4 | $6.49M | Hold |
624,288
| – | – | 0.28% | 68 |
|
|
2016
Q3 | $7.74M | Hold |
624,288
| – | – | 0.3% | 69 |
|
|
2016
Q2 | $6.71M | Hold |
624,288
| – | – | 0.27% | 77 |
|
|
2016
Q1 | $6.89M | Buy |
624,288
+150,000
| +32% | +$1.66M | 0.29% | 71 |
|
|
2015
Q4 | $5.79M | Buy |
+474,288
| New | +$5.79M | 0.21% | 84 |
|